Gland Pharma Ltd. - Research Center
543245 GLAND Group (A) BSE data
Add to watchlist
| Results |
Quarterly
|
| Statement | |
| More |
Quarterly results in brief
(Rs crore)
| Mar' 24 | Dec' 23 | Sep' 23 | Jun' 23 | Mar' 23 | |
|---|---|---|---|---|---|
| Sales | 1,174.83 | 1,097.86 | 1,010.67 | 884.07 | 785.42 |
| Operating profit | 432.83 | 369.49 | 347.10 | 259.36 | 169.15 |
| Interest | 4.53 | 0.80 | 0.91 | 1.60 | 2.18 |
| Gross profit | 475.25 | 412.08 | 387.30 | 292.97 | 205.91 |
| EPS (Rs) | 19.51 | 16.81 | 15.64 | 11.39 | 4.81 |
Quarterly
results in details
| Mar' 24 | Dec' 23 | Sep' 23 | Jun' 23 | Mar' 23 | |
|---|---|---|---|---|---|
| Other income | 46.96 | 43.39 | 41.11 | 35.21 | 38.94 |
| Stock adjustment | 26.97 | 103.70 | -22.74 | -20.49 | -76.69 |
| Raw material | 482.88 | 378.43 | 456.63 | 391.80 | 438.38 |
| Power and fuel | 28.91 | 28.62 | - | - | 29.51 |
| Employee expenses | 107.87 | 99.29 | 99.88 | 102.91 | 100.02 |
| Excise | - | - | - | - | - |
| Admin and selling expenses | - | - | - | - | - |
| Research and development expenses | - | - | - | - | - |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | 95.38 | 118.34 | 129.80 | 150.49 | 125.05 |
| Provisions made | - | - | - | - | - |
| Depreciation | 42.56 | 40.33 | 40.24 | 38.98 | 37.54 |
| Taxation | 111.28 | 94.95 | 89.54 | 66.41 | 32.70 |
| Net profit / loss | 321.41 | 276.81 | 257.53 | 187.58 | 79.21 |
| Extra ordinary item | - | - | - | - | -56.46 |
| Prior year adjustments | - | - | - | - | - |
| Equity capital | 16.47 | 16.47 | 16.47 | 16.47 | 16.47 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | - | - | - | - | - |
| Agg.of non promotoholding (%) | - | - | - | - | - |
| OPM (%) | 36.84 | 33.66 | 34.34 | 29.34 | 21.54 |
| GPM (%) | 38.90 | 36.11 | 36.82 | 31.87 | 24.98 |
| NPM (%) | 26.31 | 24.25 | 24.48 | 20.41 | 9.61 |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis